The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

Read full article: Celebrating Jane Austen: A timeless festival of literature and elegance A special meeting was held Monday night at city hall The cheapest MacBook we’ve ever seen is almost ...

Red 3—also called FD&C Red No. 3, erythrosine or E127—has been widely used in food, cosmetics and pharmaceuticals since its FDA approval in 1969. You've likely encountered Red 3 before. It's a ...

Cocoa Police said it did not appear to be gang related. A can of red spray paint was found nearby. So far, no arrests have been made. Now the police department, city officials and residents are ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

A KK Mart outlet at Kompleks Perdana Siswa (KPS) in Universiti Malaya (UM) was vandalised with red paint earlier today. This comes after UM management shuttered two KK Mart outlets on its campus ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...